Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/09/2002CN1372949A Medicine for treating pyoderma and its preparing process
10/09/2002CN1092204C Semisynthesizing method for 20(S)-ginsenoside Rg3, and use thereof in medicine
10/09/2002CN1092194C Diaminopyrimidines, pharmaceutical compositions contg. them and their use as antibacterial
10/09/2002CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/09/2002CN1092067C Medicine for treating multiple skin diseases and its preparing process
10/09/2002CN1092054C Medicine pill for detoxicating, killing bacteria anjd relieving inflammation
10/09/2002CN1092050C Mixed povidone iodine disinfectant and preparing method thereof
10/09/2002CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002US6462079 Pharmaceutical composition and method of using the same
10/08/2002US6462070 Photosensitizer conjugates for pathogen targeting
10/08/2002US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002US6462058 Benzimidazole compound crystal
10/08/2002US6462037 Such as 7-chloro-3-methyl-5-(2-cyclopropylethynyl)-1,5-dihydro-5-(trifluoromethyl) -1,4-benzodiazepin-2-one; protease inhibitors
10/08/2002US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity
10/08/2002US6461811 Gamma-herpes virus DNA and methods of use
10/08/2002US6461617 Recombinant toxin fragments
10/08/2002US6461616 EIAV p26 deletion vaccine and diagnostic
10/08/2002US6461607 Probiotic, lactic acid-producing bacteria and uses thereof
10/08/2002US6461605 Continuous low-dose cytokine infusion therapy
10/08/2002US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002US6461601 Polyalkoxy copolymers as lipase inhibitors and their compositions
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002CA2231046C Human protein kinases hyak3
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2095361C Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents
10/08/2002CA2089369C Antibacterial penem compounds
10/06/2002WO2003088897A2 Fab i inhibitors
10/06/2002CA2444597A1 Fab i inhibitors
10/06/2002CA2378565A1 Crystal structure
10/04/2002CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002WO2002077648A2 Pathogenic and commensal vaccine antigens
10/03/2002WO2002077239A1 Hcv-binding polypeptides
10/03/2002WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002WO2002077189A2 Glycosylation-resistant and nonglycosylated cyanovirins
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077022A1 Immunogenic cell surface proteins of helicobacter pylori
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077008A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
10/03/2002WO2002077007A2 Novel polyaminated fusidic acid derivatives
10/03/2002WO2002076995A2 2-amino-propanol derivatives
10/03/2002WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002WO2002076982A2 Non-nucleoside reverse transcriptase inhibitors
10/03/2002WO2002076980A1 Sialic acid derivatives
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076954A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076506A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002WO2002076500A1 Vaccine for the treatment of tubercolosis and other intracellular infections diseases
10/03/2002WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
10/03/2002WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002WO2002076483A2 Bacteriophage preparation
10/03/2002WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002WO2002076458A1 Antimicrobial drug reduced in effect on heart
10/03/2002WO2002076451A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/03/2002WO2002076439A2 Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
10/03/2002WO2002076426A2 Intravaginal drug delivery devices for the administration of an antimicrobial agent
10/03/2002WO2002076422A1 Use of a mixture comprising mn(ii) and/or zn(ii) with a hydrogenocarbonate and at least an orthodiphenol, as agent reducing adhesion of micro-organisms
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076403A2 Methods for the treatment of hiv and other viruses
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002WO2002076286A2 Prognostic methods for breast cancer
10/03/2002WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002062333A8 Use of 9h-xanthenes in a method of inhibiting viral replication targeting the nucleocapsid protein
10/03/2002WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002022657A3 Peptide antagonist of multiple chemokine receptors and uses thereof
10/03/2002WO2002014349A3 Non-covalent inhibitors of urokinase and blood vessel formation
10/03/2002WO2002000242A3 Human papilloma virus treatment
10/03/2002WO2001085095A3 Chiral fluoroquinolizinone arginine salt forms
10/03/2002WO2001083754A3 Cellular regulators of infectious agents and methods of use
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001029020A9 Neuraminidase inhibitors
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2000073502A3 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143149 Seven trans-membrane receptor-Fitz2
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143066 Perylenequinones for use as photosensitizers and sonosensitizers
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143013 Thioxazinoquinolones as antiviral agents
10/03/2002US20020143009 Novel bicyclic oxazolidinones as antibacterial agents
10/03/2002US20020142991 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine
10/03/2002US20020142984 Administering a positively charged liposome to animal, wherein positively charged liposome is associated with nucleic acid molecule, wherein nucleic acid molecule is in operable association with a promoter
10/03/2002US20020142948 Methods for administration of antibiotics
10/03/2002US20020142296 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins
10/03/2002US20020142290 Compound for use in the treatment of viral diseases
1 ... 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 ... 1798